Literature DB >> 9585742

Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus.

S V Koskinen1, A R Reunanen, T P Martelin, T Valkonen.   

Abstract

OBJECTIVES: This paper presents detailed cause-specific data about excess mortality among diabetic persons in Finland, by age and sex.
METHODS: Five-year follow-up data on the Finnish population aged 30 through 74 years were analyzed. During these 5 years, 11,215 persons with diabetes and 102,843 persons without diabetes died. The diabetic population was defined as people who were entitled to free medication for diabetes at the beginning of the follow-up period, that is, at the end of 1980.
RESULTS: The relative mortality of persons with drug-treated diabetes compared with nondiabetic persons was higher among women (3.4) than among men (2.4). Almost three quarters of the mortality excess was due to circulatory diseases. For most other causes of death, too, diabetic persons had higher than average mortality. The exceptions were lung cancer, chronic obstructive pulmonary disease, and alcohol poisoning.
CONCLUSIONS: Diabetes is a general risk factor for untimely death and makes a significant contribution to overall national death rates, particularly for circulatory diseases. Lower than average mortality from smoking-related diseases and alcohol poisoning, however, warrant optimism about the effects of health education among diabetic persons.

Entities:  

Mesh:

Year:  1998        PMID: 9585742      PMCID: PMC1508922          DOI: 10.2105/ajph.88.5.765

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  41 in total

1.  LONGEVITY AND MORTALITY OF DIABETICS.

Authors:  H H MARKS
Journal:  Am J Public Health Nations Health       Date:  1965-03

2.  Mortality from cardiovascular diseases among diabetics.

Authors:  A S Królewski; A Czyzyk; D Janeczko; J Kopczyński
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

3.  Epidemiological studies of diabetes mellitus in Denmark: 5. Mortality and causes of death among insulin-treated diabetic patients.

Authors:  A Green; P Hougaard
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

4.  Mortality in type 2 diabetes.

Authors:  A Reunanen
Journal:  Ann Clin Res       Date:  1983

5.  Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus.

Authors:  M Ragozzino; L J Melton; C P Chu; P J Palumbo
Journal:  J Chronic Dis       Date:  1982

6.  Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

7.  Prognosis of diabetes mellitus in a geographically defined population.

Authors:  G Panzram; R Zabel-Langhennig
Journal:  Diabetologia       Date:  1981-06       Impact factor: 10.122

8.  Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study.

Authors:  E Barrett-Connor; D L Wingard
Journal:  Am J Epidemiol       Date:  1983-10       Impact factor: 4.897

9.  Diabetes and cardiovascular risk factors: the Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

10.  Trends in regional and socio-economic mortality differentials in Finland.

Authors:  T Valkonen
Journal:  Int J Health Sci       Date:  1992
View more
  16 in total

1.  Causes of death among diabetic patients in Denmark.

Authors:  M B Hansen; M L Jensen; B Carstensen
Journal:  Diabetologia       Date:  2011-11-30       Impact factor: 10.122

2.  Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study.

Authors:  N A Roper; R W Bilous; W F Kelly; N C Unwin; V M Connolly
Journal:  BMJ       Date:  2001-06-09

3.  Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults.

Authors:  R Valdez; K M Narayan; L S Geiss; M M Engelgau
Journal:  Am J Public Health       Date:  1999-11       Impact factor: 9.308

Review 4.  The global epidemiology of hepatocellular carcinoma: present and future.

Authors:  Katherine A McGlynn; W Thomas London
Journal:  Clin Liver Dis       Date:  2011-05       Impact factor: 6.126

5.  Population-based estimates of mortality associated with diabetes: use of a death certificate check box in North Dakota.

Authors:  E F Tierney; L S Geiss; M M Engelgau; T J Thompson; D Schaubert; L A Shireley; P J Vukelic; S L McDonough
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

6.  Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden.

Authors:  I Waernbaum; G Blohmé; J Ostman; G Sundkvist; J W Eriksson; H J Arnqvist; J Bolinder; L Nyström
Journal:  Diabetologia       Date:  2006-01-31       Impact factor: 10.122

7.  Diabetes mellitus and gastric carcinoma: Is there an association?

Authors:  Sathiya P Marimuthu; Paari Vijayaragavan; Kirsten B Moysich; Vijayvel Jayaprakash
Journal:  J Carcinog       Date:  2011-12-02

8.  The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese.

Authors:  Ming-Chia Hsieh; Tzu-Chi Lee; Shu-Min Cheng; Shih-Te Tu; Ming-Hong Yen; Chin-Hsiao Tseng
Journal:  Exp Diabetes Res       Date:  2012-06-05

9.  Increased cancer mortality in diabetic people treated with insulin: a register-based follow-up study.

Authors:  Erja Forssas; Reijo Sund; Kristiina Manderbacka; Martti Arffman; Pirjo Ilanne-Parikka; Ilmo Keskimäki
Journal:  BMC Health Serv Res       Date:  2013-07-09       Impact factor: 2.655

10.  Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer.

Authors:  Samantha F Ehrlich; Charles P Quesenberry; Stephen K Van Den Eeden; Jun Shan; Assiamira Ferrara
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.